Advanced Search

column
Antiviral research and drug development targeting the solute carrier superfamily (SLCs)
DING Liyun, LIU Dongyu, ZHOU Ting, PAN Wei, BIAN Jinlei
2026, 57(4): 411-421. DOI: 10.11665/j.issn.1000-5048.2026012304
Abstract PDF
Structural basis of heteromeric amino acid transporters and advances in targeted drug development
DAI Lu, XU Chenye, WANG Xiaoting, LIANG Hao, ZHANG Shuo, YAN Renhong
2026, 57(4): 422-433. DOI: 10.11665/j.issn.1000-5048.2026022804
Abstract PDF
Hepatic cell-specific expression patterns, molecular mechanisms, and therapeutic targeting strategies of solute carrier transporters in drug-induced liver injury
CHAI Yalei, XIONG Jing
2026, 57(4): 434-442. DOI: 10.11665/j.issn.1000-5048.2026022001
Abstract PDF
Roles and research progress of the SLC13A5-driven metabolic-inflammatory axis in metabolic diseases, cancers and neurological disorders
LI Yanzhen, ZHANG Ziyi, HU Wenjun, TAO Yitong, QIU Zhixia
2026, 57(4): 443-452. DOI: 10.11665/j.issn.1000-5048.2026013102
Abstract PDF
Synthesis and antidiabetic activity evaluation of benzopyrimidine-7-azaindole derivatives targeting TXNIP/DYRK1A
CUI Yucan, WANG Yaning, WANG Jing, LI Aiyun, SU Wanzhen, HE Hong, LI Weize, GUAN Li
2026, 57(4): 453-459. DOI: 10.11665/j.issn.1000-5048.2025061601
Abstract PDF
Research on the transformation of diisopropyl azodicarboxylate (DIAD) in gas chromatography and the development of its residual determination method
CHEN Shuai, YAO Junliang, YIN Daquan
2026, 57(4): 460-465. DOI: 10.11665/j.issn.1000-5048.2025102302
Abstract PDF
Mitophagy-mediated inhibition of glioma proliferation by cannabidiol-loaded hybrid exosomal vesicles
HAN Wenhui, SHEN Yan, CHEN Daquan, LIU Ji
2026, 57(4): 466-478. DOI: 10.11665/j.issn.1000-5048.2025120401
Abstract PDF
Xuanbi Xuanfuhua Decoction intervenes in pulmonary source sepsis in rats by regulating PANapoptosis-related proteins
WANG Guangyao, XIE Sheng, LI Liqun, TAN Jinjing, LIU Yuanyuan, LIANG Jing, HONG Xiaohua
2026, 57(4): 479-489. DOI: 10.11665/j.issn.1000-5048.2025052602
Abstract PDF
Investigation of the mechanisms underlying the anti-atherosclerotic effects of Tianxiangdan Capsules through inhibition of pyroptosis via the GPER/NLRP3 pathway
WANG Hongxiang, JIANG Lin, LI Yu, HUANG Wenjuan, RONG Xing, ZHAO Shuangzhu
2026, 57(4): 490-497. DOI: 10.11665/j.issn.1000-5048.2025123102
Abstract PDF
Establishment of a zebrafish migraine model and pharmacodynamic evaluation of Tianshu Capsules
JIANG Shan, ZHANG Qiqi, LI Juan, ZHANG Xinzhuang, LIU Jun
2026, 57(4): 498-504. DOI: 10.11665/j.issn.1000-5048.2026010501
Abstract PDF
Therapeutic efficacy of Xiao’er Guangpu Zhixie Oral Liquid against bacterial diarrhea
CAO Jiarui, CAO Qianyue, CHI Ruoyang, CHEN Yizhu, JIANG Yuge, ZHANG Yayun, ZHAO Xiaoqing, MA Lingman
2026, 57(4): 505-515. DOI: 10.11665/j.issn.1000-5048.2026012001
Abstract PDF
Knowledge graph prediction and molecular docking validation of drug repositioning candidates for hepatic fibrosis
YAN Yiyun
2026, 57(4): 516-524. DOI: 10.11665/j.issn.1000-5048.2026062801
Abstract PDF
Virus-like particles and their applications in the treatment of rare diseases
DAI Haoran, JU Caoyun
2026, 57(4): 525-533. DOI: 10.11665/j.issn.1000-5048.2026041301
Abstract PDF
Recent progress in China’s radiopharmaceuticals
HU Kuan, GAO Xin, WANG Rui
2026, 57(4): 534-539. DOI: 10.11665/j.issn.1000-5048.2026060101
Abstract PDF
Advances in research on methods and applications of AI-based drug design in China
RU Jinxiao, WANG Yifei, YANG Shengyong
2026, 57(4): 540-550. DOI: 10.11665/j.issn.1000-5048.2026060203
Abstract PDF

Total visits：